ABS Policies in Canada
6) Contribute to the Improvement of the
Health of Canadians
By providing the conditions for efficient access to genetic resources, ABS policy offers the opportunity to promote the discovery of new bio-active compounds that contribute to the health of Canadians. For example, a drug developed by ABS pioneer Shaman Pharmaceuticals, is now being brought to final round of clinical trials. This drug may have a large impact on infant mortality in the developing world as it prevents diarrhoea through a new biological mechanism that avoids the side effects of current medicines 11. In a broader sense, the potential use of biological processes instead of petroleum products or high energy chemical ones will reduce our industry's environmental footprint, leading to a healthier environment for Canadians.
11Philipkoski, Kristen. (July 11, 2005). A Drug to Eradicate Diarrhea. See:
accessed July 18, 2005.
- Foreword - Investing in Natural Capital: Sustaining Biodiversity in the "Bio-based Economy"
- The Key Challenge of ABS: Fostering a Common Approach
- Public Policy Objectives
- 1 ) Promoting the Conservation and Sustainable Use of Canada's Biodiversity
- 2) Improve Canada's Economic Competitiveness in the Bio-based Economy
- 3) Support Ethical Scientific Research and Development
- 4) Foster Regional and Aboriginal Development
- 5) Support Canada's Foreign Policy Objectives
- 6) Contribute to the Improvement of the Health of Canadians
- Policy Questions in Implementing ABS
- Principles and Features of Canadian ABS Policies
- Date Modified: